Abstract. Radical hysterectomy and pelvic lymphadenectomy is recommended for stage Ia2-Ib1 cervical cancer while parametrial involvement (PI) is rare. Our aim was to evaluate criteria to select women with low risk of PI that could benefit from simple hysterectomy. Factors associated with low risk of PI were analyzed in a series of 37 patients with stage Ia2-Ib1 cervical cancer undergoing radical hysterectomy and sentinel lymph node procedure from 2003 to 2008. PI was associated with tumor size (p<0.001) and lymphovascular space invasion (LVSI) (p=0.007). PI was found in 4.5% of patients with tumor size ≤2 cm versus 33% with tumor size >2 cm (p=0.04). The negative predictive value was 100% for absence of LVSI (95% CI: 0.83-1) and for combinations: tumor size ≤2 cm and SN negative (95% CI: 1-1), tumor size ≤2 cm and no LVSI (95% CI: 0.86-1), tumor size ≤2 cm and tumor grade 1-2 and no LVSI (95% CI: 0.82-1), and tumor size ≤2 cm and PLN negative and no LVSI (95% CI: 0.83-1). Among various combinations, a tumor size ≤2 cm and absence of LVSI appears the most relevant to predict parametrial status.
Introduction
Radical hysterectomy and pelvic lymphadenectomy is the gold standard to treat patients with early-stage cervical cancer (stage Ia2 and Ib1) (1) (2) (3) . Although the anatomical concept of the parametrium has recently been discussed (4, 5) , parametrectomy remains an integral part of surgical treatment and defines the radicality of hysterectomy (1) . Parametrium involvement (PI) is low in the early stages of cervical cancer (6) (7) (8) affecting only 8% of women with negative pelvic lymph nodes in early-stage (9) (10) (11) . However, parametrectomy is the most difficult step of radical hysterectomy and the main source of complications: severe perioperative complications occurred in 10-15% of patients and late urologic and rectal dysfunctions related to nerve injury in 20-30% raising the issue of its legitimacy (12) (13) (14) . Moreover, previous studies support that reduction in radicality did not seem to impact on prognosis while the incidence of complications decreased (6, 7, 13) .
The main challenge for the oncologist is therefore to identify which women with early-stage cervical cancer carry a low risk of PI and could thus benefit from simple hysterectomy without compromising prognosis. Strnad et al questioned the relevance of systematic parametrectomy in early-stage cervical cancer when tumor size measured <2 cm, stromal infiltrationwas <16 mm and there was no lymphovascular space invasion (LVSI) (3) . However, they did not take into account pelvic lymph node (PLN) status which is directly associated with the risk of PI. Recently, it has been suggested that the sentinel node (SN) procedure is a potential tool to tailor the radicality of hysterectomy (3, 15) .
We were therefore prompted to evaluate the criteria identifying women with a low risk of PI who could benefit from simple hysterectomy in a series of patients with early stages of cervical cancer treated by radical hysterectomy and sentinel node procedure.
Materials and methods
Between July 2003 and July 2008, 37 of 105 women with cervical cancer referred to the gynecology unit of Tenon Hospital, France had early-stage cervical cancer corresponding to FIGO (International Federation of Gynecology and Obstetrics) stage Ia2 to Ib1. Eligibility criteria were: squamous, adenosquamous or adenocarcinoma histology and no contraindication to surgery. Women with stage Ia1 were excluded from the study as parametrectomy was not indicated in these patients in accordance with our protocol, as were those with FIGO Ib2 to IV stages and patients treated exclusively with concurrent chemoradiotherapy. All gave their informed consent before treatment. All 37 women had biopsy-or conization-proven cervical cancer and underwent preoperative blood sampling, chest X-ray examination, and pelvic magnetic resonance imaging (MRI). Tumor size was assessed by both pelvic examination and MRI. The medical records were prospectively recorded in a database to determine age, body mass index (BMI), FIGO stage, tumor size in cm, surgical procedure, pathologic findings [tumor histology, histological grade: well differentiated (grade 1), moderately differentiated (grade 2) and poorly differentiated (grade 3)], presence of LVSI, histological tumor size, stromal infiltration, PI, vaginal involvement, surgical margins, and PLN status including SN status, and operative time. PI was defined as tumor cells within the parametrium. The protocol was approved by the ethics committee.
Patients underwent initial laparoscopic pelvic lymphadenectomy and SN procedure and vaginal or laparoscopic radical hysterectomy. In women wishing to preserve their childbearing potential, a radical vaginal trachelectomy was performed as a fertility sparing treatment. After final histology analysis, patients with adverse prognostic factors underwent adjuvant therapy (radiotherapy and/or chemotherapy). SN biopsy and pathological SN examination methods were performed as previously described (15) . In accordance with the Philadelphia Consensus Conference and previous studies on SN procedure in cervical cancer (16, 17) , the following definitions of lymph node metastases were used: macrometastases as a single focus of metastatic disease per node measuring >2 mm, micrometastases as a focus of metastatic disease ranging from 0.2 mm to ≤2 mm and, in accordance with Marchiole et al, submicrometastases as metastases measuring ≤0.2 mm (including the presence of single noncohesive tumor cells) (16, 18, 19) . SNs were considered positive when they contained macrometastases, micrometastases or submicrometastases. When SN involvement was detected intraoperatively by imprint cytology, paraaortic lymphadenectomy was performed.
Comparisons between continuous and dichotomous variables were based on the Student-t test or the MannWhitney U-test. Comparisons between dichotomous variables were based on the Pearson Chi-square test or Fisher's test. We reported factors associated with a low risk of PI as tumor size ≤2 cm, absence of LVSI, tumor grade 1 or 2, negative SN at final histology, negative PLN at final histology. We also studied the combined variables as tumor size ≤2 cm and SN negative at final histology; tumor size ≤2 cm and PLN negative at final histology; tumor size ≤2 cm and absence of LVSI; tumor size ≤2 cm and tumor grade 1 or 2 and absence of LVSI; and finally tumor size ≤2 cm and PLN negative at final histology and absence of LVSI. We calculated a number of false negatives (FN), true negatives (TN), false positives (FP) and true positives (TP) and calculated a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) with a 95% confidence interval of NPV. We also reported a negative likelihood ratio (NLR) and its 95% confidence interval. A p-value <0.05 was considered to denote a significant difference. Statistical analysis was performed using the R package with the Survival, Design, Hmisc, Rpart, and Verification libraries (http://lib.stat.cmu. edu/R/CRAN/).
Results
The median age of the 37 patients was 50. had PI and these six also had LVSI. Clinical and pathological data were compared by tumor size ≤2 cm and >2 cm. Age, PI and operative time were higher in patients with tumor size >2 cm (Table I) .
At least one SN was detected in 32 patients. The identification rate was 86.7%. The mean number of SN removed was 2.7 per patient (range: 1-8). Six (18.8%) of the 32 patients had at least one positive SN. The histological results for SN and non-SN are given in Table II . Intra-operative examination by imprint cytology of SN was positive for only one of the six SN-positive patients including three macrometastases. Sensitivity and NPV of imprint cytology were 0.167 (95% confidence interval: 0.04-0.17) and 0.865 (95% confidence interval: 0.84-0.87) respectively, with an FN rate of 13.5%. The patient with SN metastases detected by imprint cytology underwent paraaortic lymphadenectomy with 15 negative paraaortic lymph nodes. Among the six patients with positive SN at final histology, three had macrometastasis, two had micrometastasis detected by H&E and one patient had submicrometastasis detected by IHC. All patients underwent bilateral pelvic lymphadenectomy of external iliac, interiliac, and superficial obturator nodes, and a mean of 9.6 nodes were removed per patient (range: 2-21). No patient had positive pelvic non-SNs. Therefore, the FN rate of the SN procedure was 0. The mean number of SNs removed was higher in patients with tumor size ≤2 cm than in patients with tumor size >2 cm [3.2 (range: 1-8) versus 1.9 (range: 1-5), p<0.001]. The identification rate was similar in both groups: 19 of the 22 patients (86.4%) with tumor size ≤2 cm and 13 of the 15 patients (86.7%) with tumor size >2 cm. A trend for a higher bilateral SN detection was noted in patients with tumor size ≤2 cm versus tumor size >2 cm (68.4% versus 30.8% respectively, p=0.07). PLN involvement was found in 18.2% (4/22) of patients with tumor size ≤2 cm and 13.3% (2/15) of patients with tumor size >2 cm (p=1). Among the four positive-SN patients with tumor size ≤2 cm, macrometastasis and micrometastasis in H&E was detected in two patients each. Among the two positive-SN patients with tumor size >2 cm, macrometastasis and submicrometastasis in IHC was detected in each patient (p=0.6).
PI was strongly associated with tumor size (p<0.001), presence of LVSI (p=0.007), and vaginal involvement (p=0.04) but not with SN or PLN involvement, histology or histological grade (Table III) . PI was found in 4.5% of patients (1/22) with a tumor size ≤2 cm versus 33% of patients (5/15) with a tumor size >2 cm (p=0.04). Among the 11 patients (29.7%) with LVSI, six (55.5%) had PI. No PI was reported in the 26 patients without LVSI. Clinical and pathological data of the six patients with PI are reported in the Table IV. The patient with a tumor size ≤2 cm had poorly differentiated epidermoid carcinoma. All patients had LVSI. One of the six patients had PLN involvement (one macrometastasis SN).
To apply a pragmatic clinical approach, we particularly studied variables classically reported as determinant factors associated with a low risk of PI: tumor size ≤2 cm, absence of LVSI, tumor grade 1 or 2, SN negative at final histology, PLN negative at final histology and combined variables as tumor size ≤2 cm and SN negative at final histology; tumor size ≤2 cm and PLN negative at final histology; tumor size ONCOLOGY REPORTS 22: 927-934, 2009 Table I . Clinical and pathological data of the 37 patients with cervical cancer FIGO stage Ia2 and Ib1: overall and tumor size ≤2 cm versus >2 cm.
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≤2 cm and absence of LVSI; tumor size ≤2 cm and tumor grade 1 or 2 and absence of LVSI; and finally tumor size ≤2 cm and PLN negative at final histology and absence of LVSI (Table V) . The NPV was 100% for absence of LVSI (95% confidence interval: 0.83-1) and for four combinations of variables: tumor size ≤2 cm and SN negative (95% confidence interval: 1-1), tumor size ≤2 cm and absence of LVSI (95% confidence interval: 0.86-1), tumor size ≤2 cm and tumor grade 1 or 2 and absence of LVSI (95% confidence interval: 0.82-1), and tumor size ≤2 cm and PLN negative at final histology and absence of LVSI (95% confidence interval: 0.83-1). The last combination applied to patients undergoing a vaginal trachelectomy (Table V) .
Discussion
The present study has demonstrated that pre-operative characteristics of early cervical cancer stages are useful to select a subgroup of patients for whom systematic parametrectomy could be avoided.
We show that combinations of clinical and histological variables are more relevant to predict PI than the use of a single variable. Using single variables, only the absence of LVSI had a NPV of 100% in predicting the absence of PI while tumor size <2 cm, low tumor grade, and negative SLN or PLN status had lower NPVs. This is in accordance with previous studies showing that LVSI was directly related to the risk of lymph node involvement (18) . Moreover, previous studies have underlined that lymph node metastases were correlated to PI (20) . Using multivariate analysis, LVSI emerged as a major predictive factor of survival (21) . To preclude the risk of underestimation of PI using a single variable, several combinations were tested. An NPV of 100% was found for four combinations: i) tumor size ≤2 cm and SN negative at final histology; ii) tumor size ≤2 cm and absence of LVSI; iii) tumor size ≤2 cm and tumor grade 1 or 2 and absence of LVSI; iv) tumor size ≤2 cm and PLN negative at final histology and absence of LVSI. Among these combinations, two are potentially available pre-operatively to select patients at low risk of PI: tumor size ≤2 cm and absence Table II . Histology of sentinel and non-sentinel lymph nodes and outcome of 37 patients with cervical cancer FIGO stage Ia2 and Ib1: overall and tumor size ≤2 cm versus >2 cm. --------------------------------------------------------------------------------------------------- 
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SN, sentinel node; LVSI, lymphovascular space involvement; Nb, number; H&E, hematoxylin and eosin; IHC, immunohistochemistry. Table III . Clinical and pathological data of the 37 patients with cervical cancer FIGO stage Ia2 and Ib1: overall and patients with parametrial involvement versus without parametrial involvement. --------------------------------------------------------------------------------------------------- of LVSI and tumor size ≤2 cm and tumor grade 1 or 2 and absence of LVSI. Among these two combinations, tumor size ≤2 cm and absence of LVSI appeared particularly relevant due to a narrow 95% confidence interval (CI) while adding tumor grade increased the CI width. Our results support the use of this combination to select patients that could benefit from a simple hysterectomy. Moreover, although our series included only two patients who underwent vaginal radical trachelectomy, our results raise the issue of the possible use of conization in patients fulfilling these criteria due to the low risk of PI.
-----------------------------------------------------------------------------------------------------
Using the combination of a tumor size ≤2 cm and absence of LVSI to select early-stage cervical cancer patients for a simple hysterectomy might expose them to the risk of undertreatment if PLN involvement is not taken into account. Positive PLNs have been reported as a major predictive factor of a high risk of PI (3, 6, 13, (22) (23) (24) . However, in our study, only one patient with PI had positive SLN (macrometastases) while five had PI with negative PLN. Rob et al reported that none of their negative-SLN patients with tumor size <3 cm had PI (24) . In a subgroup of patients with tumor size <2 cm and stromal invasion <50%, Strnad et al found Table III . Continued. ---------------------------------------------------------------------------------------------------- 
SN, sentinel node; LVSI, lymphovascular space involvement; Nb, number; H&E, hematoxylin and eosin; IHC, immunohistochemistry. Table IV . Clinical, pathological data and outcome of patients with parametrial involvement according to the tumor size ≤2 cm or >2 cm. 
SCC, squamous cell carcinoma; adenoc, adenocarcinoma; LVSI, lymphovascular space involvement; SN, sentinel lymph node; non-SN, non-sentinel lymph node; RFS, relapse-free survival.
that PI was observed in 27% (3/11) of patients with positive SLN versus 0% (0/80) in patients with negative SLN (3). Stegman et al reported that only 5 of 799 patients (0.63%) with early cervical carcinoma <2 cm, infiltration depth <10 mm and negative PLN had PI (11) . Finally, Panici et al reported PI in only 3% of cases with negativePLN versus 100% of cases in positive PLN (13) . All these data (3, 11, 13, 24) raise the issue of histological techniques to assess lymph node status both intra-operatively and on final histology. In the present study, none of the six patients with positive SLN were detected by intra-operative histology reflecting the low accuracy of imprint cytology. However, serial sectioning and IHC allowed three of the five SLN-positive patients without PI to be identified, reinforcing the contribution of ultrastaging Hence, there is a need for a better assessment of lymph node status. One option could be to opt for an initial pelvic lymphadenectomy with the SLN procedure followed by a second surgery after final histology. This option could be relevant for patients wishing to preserve their childbearing potential due to the less aggressive nature of conization compared to radical trachelectomy, but appears questionable for the vast majority of patients related to cumulative risks associated with a second surgery (11) .
To avoid a two-step surgical treatment of early-stage cervical cancer, it might be necessary to increase the accuracy of intra-operative histology. In this study, accuracy of imprint cytology was poor. Sensitivity and NPV were 0.17 (95% CI: 0.04-0.17) and 0.86 (95% CI: 0.84-0.87) respectively, with an FN rate of 13.5%. Hence, combinations including SLN status appeared less relevant due to the low accuracy of imprint cytology to detect lymph node involvement. Previous studies have underlined the contribution of intra-operative histology based on frozen section but this is associated with loss of tissue sample for definitive histology (13, (25) (26) (27) . The sensitivity, NPV and FN rates of frozen section reported by Panici et al were 90, 97, and 4.2%, respectively (13) . In various series, FN rates ranged from 4.2 to 32% (13, (25) (26) (27) . To improve the accuracy of intra-operative histology, several biological techniques based on RT-PCR have been proposed using both cytokeratin 19 and human papillomavirus but were not able to differentiate between types of metastases (15, 28) . Although issues remain about the relevance of micrometastases in women with cervical cancer (16) , differentiating between true macrometastases and multiple micrometastasis or submicrometastasis seems particularly relevant as previous clinical studies have underlined the risk of recurrence and poor survival according to the type of metastases (16) . To remedy this concern, in breast cancer, correlation has been established between the number of copy cells and the size of metastases but requires confirmation in cervical cancer.
Some limitations of the present study have to be underlined. First, we did not take into account MRI features suggestive of PI. Postema et al reported that the sensitivity of MRI to detect PI was 89% compared to 44% for pelvic examination alone but included both early and advanced stages of cervical cancer (29) . In the present study, all the patients with earlystage cervical cancer underwent a pre-operative MRI that did not detect PI. Second, the small sample size did not allow us to draw definitive conclusions. However, from a statistical viewpoint, our pragmatic proposal seems robust enough. Finally, the present study represents the experience of one team with potential bias linked to department recruitment and requires confirmation on the usefulness of our combination by others teams.
In conclusion, our results support that the combination of pre-operative characteristics of early-stage cervical cancer could be useful to select patients for less aggressive surgery and hence potentially contribute to a decrease in surgical morbidity. Moreover, among the various combinations studied, a tumor size ≤2 cm and the absence of LVSI appears easy to assess and the most relevant predictor of parametrial status. ONCOLOGY REPORTS 22: 927-934, 2009 Table V. Predictive factors of low risk of parametrial involvement in patients with early-stage cervical cancer. 
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a At final histology; Nb, number; LVSI, lymphovascular space involvement; SN, sentinel lymph node; PLN, pelvic lymph node; FN, false negative; NPV, negative predictive value.
